RESEARCH-USE BIOSIMILAR ANTIBODY
Utomilumab
Monoclonal antibody · IgG2
Utomilumab (PF 05082566) is a fully human IgG2 agonist monoclonal antibody that selectively binds to 4-1BB/CD137. Utomilumab can be used in the research of tumors such as follicular and other CD20+ non-Hodgkin lymphomas.
TARGETTNFRSF9
YMonoclonal antibody
CATALOGSC-BS-055
CATALOG NUMBERSC-BS-055
MOLECULAR WEIGHTApprox. 142.78 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Utomilumab (PF 05082566) is a fully human IgG2 agonist monoclonal antibody that selectively binds to 4-1BB/CD137. Utomilumab can be used in the research of tumors such as follicular and other CD20+ non-Hodgkin lymphomas.
Utomilumab is a recombinant research-use antibody directed against TNFRSF9.